Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Heyan Danggui Yixue is a Traditional Chinese Medicine (TCM) hospital preparation developed by the First Hospital of Hebei Medical University. It is primarily formulated as an oral liquid (Danggui Yixue Koufuye) and is indicated for the treatment of abnormal uterine bleeding, anemia, and syndromes characterized by Qi and blood deficiency. The preparation leverages the pharmacological properties of *Angelica sinensis* (Danggui) and other herbal components to promote hematopoiesis, improve microcirculation, and regulate uterine smooth muscle tone. It is widely used in clinical practice within the developing institution's network to manage gynecological disorders and hematological deficiencies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Heyan Danggui Yixue.